Machine Learning Application in a Phase I Clinical Trial Allows to Identify Clinical‐Biomolecular Markers Significantly Associated with Toxicity

Author(s):  
Luca Bedon ◽  
Erika Cecchin ◽  
Emanuele Fabbiani ◽  
Michele Dal Bo ◽  
Angela Buonadonna ◽  
...  
Sign in / Sign up

Export Citation Format

Share Document